ERJ open research · 2025
Serum immunoglobulin A as a biomarker for respiratory syncytial virus infection in children aged <2 years.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Moureau Annick, Mikolajczyk Rafael, Gottschick Cornelia, Klee Bianca, van Binnendijk Rob, Schepp Rutger, Thwaites Ryan S, Zhang Donghui, Jia Yichen, Vernhes Charlotte, PROMISE investigators
Аннотация
AIMS: Past research suggested respiratory syncytial virus (RSV) specific serum immunoglobulin A (IgA) antibodies as a biomarker of previous RSV infections in young infants accounting for maternal immunity. This study aimed to confirm this association and to establish a serological threshold for discriminating RSV-naïve infants from those who have experienced RSV.
MATERIAL AND METHODS: This study involves 135 infants from the LoewenKIDS study with nasal swabs collected at each acute respiratory infection, and serum samples collected at ages 1 and 2 years. RSV presence in swabs was ascertained by reverse transcriptase PCR; RSV-specific IgG and IgA antibody levels against five different structural proteins and RSV neutralising antibodies were measured in sera. Robust Mixture Discriminant Analysis was used to determine the cut-off values and account for false negatives.
RESULTS: Of 135 included infants, 131 had available data at year 1 (Y1) and 95 at year 2 (Y2). Pre-F IgA concentrations were higher in infants with PCR-confirmed RSV infections. There was a further increase in IgA, IgG and neutralising antibody titre concentrations from Y1 to Y2 consistent with re-infections. Based on robust mixture discriminant analysis, the cut-off values of pre-F IgA level indicative of past RSV infection were 0.23 AU·mL-1 at Y1 and 0.22 AU·mL-1 at Y2.
CONCLUSION: This study shows that in children aged <2 years, a previous RSV infection is accompanied by serum pre-F IgA antibody levels above 0.22 AU·mL-1, a value close to a previously proposed cut-off (0.19 AU·mL-1) based on seroresponse data only. The confirmed threshold can be of use in studies assessing vaccination strategies.
MATERIAL AND METHODS: This study involves 135 infants from the LoewenKIDS study with nasal swabs collected at each acute respiratory infection, and serum samples collected at ages 1 and 2 years. RSV presence in swabs was ascertained by reverse transcriptase PCR; RSV-specific IgG and IgA antibody levels against five different structural proteins and RSV neutralising antibodies were measured in sera. Robust Mixture Discriminant Analysis was used to determine the cut-off values and account for false negatives.
RESULTS: Of 135 included infants, 131 had available data at year 1 (Y1) and 95 at year 2 (Y2). Pre-F IgA concentrations were higher in infants with PCR-confirmed RSV infections. There was a further increase in IgA, IgG and neutralising antibody titre concentrations from Y1 to Y2 consistent with re-infections. Based on robust mixture discriminant analysis, the cut-off values of pre-F IgA level indicative of past RSV infection were 0.23 AU·mL-1 at Y1 and 0.22 AU·mL-1 at Y2.
CONCLUSION: This study shows that in children aged <2 years, a previous RSV infection is accompanied by serum pre-F IgA antibody levels above 0.22 AU·mL-1, a value close to a previously proposed cut-off (0.19 AU·mL-1) based on seroresponse data only. The confirmed threshold can be of use in studies assessing vaccination strategies.